Lung CT Scan
Lung cancer screenings often involve a CT scan as part of a comprehensive physical workup. CT scans provide detailed, cross-sectional images of the lungs and the surrounding tissues/organs, and are capable of producing much higher-quality images than ordinary X-rays alone. By looking at a patient’s CT scan, a physician can check for any unusual lesions that might have started to develop in the lungs, then determine if any additional testing might be necessary.
Low-dose CT scans are safe and effective at identifying developments that could potentially be cancerous. As such, the United States Preventative Services Task Force recommends that people who meet the following criteria receive one each year as part of a lung cancer screening regime:
- Anyone who is between the ages of 55 and 77, and
- Has a 30 pack/year smoking history, and
- Is a current smoker or has quit smoking within the past 15 years
At Moffitt Cancer Center, our Lung Cancer Screening and Surveillance Program offers yearly CT scans, along with other measures such as smoking cessation and tobacco treatment programs. If a patient’s lung CT scan indicates that cancer might be present, the images will be sent to our multispecialty tumor board for a detailed review. From there, we can help each patient determine if additional diagnostic testing, such as a tissue biopsy, should be performed. Moffitt’s lung cancer screening program is among the best in the nation, and for our efforts, we have been named a Screening Center of Excellence by the Lung Cancer Alliance.
No referral is required for entry into our Lung Cancer Screening and Surveillance Program. To schedule your lung CT scan, call 1-888-663-3488 or submit a new patient registration form.
Lung Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer